Smoking cessation after NSCLC diagnosis cuts mortality risk
(HealthDay)—For patients with non-small cell lung cancer (NSCLC), smoking cessation after diagnosis is associated with a reduced risk for all-cause […]
» Read moreHome »
Tagrisso (osimertinib) received approval as an adjuvant treatment for patients with non-small cell lung cancer with epidermal growth factor receptor […]
Tagrisso approved as adjuvant therapy for NSCLC with EGFR mutations
